INO
SRNE - Beginning of the big move.Currently shorts are controlling the stock. Seems that it found it's support and we might see a short squeeze in the upcoming 1-3 weeks.
Ready to Pop! Explained.We need to see volulme to commit to that great break. The upside of the trade is huge and a tight stoploss at every support would serve you well.
Minimun 100 for daytrading and 50 for swing trade.
Good luck!
Very Bullish setup for INOEntered a swing calls Friday morning. First take profit point is the upcoming dotted red line (13.00) and the second take profit line is 18.55. I believe the momentum of a 2nd surge and upcoming catalysts with the massive 14 million dark pool buy right before the close on Friday will make INO rise in the short to mid term.
$INO: bullish patters/TA/ EW Ridiculous support + retest. Solid bullish call with the other vaccine-makers going bullish
**REQUEST** $AAL $INO $DKNG $SRNE *QUICK TA*Thanks @smallcapper on Stocktwits for reaching out! Here ya go!
LONG $DGX ER run up ($MRNA $GILD $INO $SPY)see charts at www.tradingview.com
$DGX Entry 120
Target 1 $125
Target 2 $130
Why DGX?
FDA Authorizes Quest Diagnostics COVID-19 Nasal Specimen Self-Collection Kit for Emergency Use
With Covid wave 2 on the rise, this could be a huge player.
www.prnewswire.com
What is DGX?
Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, United Kingdom, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
Long Gild - Covid Drug ($MRNA $GSK $INO $SPY $PFE $JNJ $MRK)see full chart at www.tradingview.com
Gild
Entry $62 area
Target 1 $67
Target 2 $71
stoploss $59
Why this play?
Trump used Gild's drug as part of his treatment, if he pulls thru with a full recovery. they will probably start pumping the news about this company and it'll finally have enough momentum to move back to the upside.
What is Gild?
Gilead Sciences, Inc., is an American biopharmaceutical company headquartered in Foster City, California that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
Notable price upgrades
Sep-30-20 Resumed Jefferies Buy $78
Sep-15-20 Upgrade Maxim Group Hold → Buy $88
INO Short Squuze on the way soon Currently 28.8% short interest with the Weekly just above the 200 EMA. Oversold Stoch and at the bottom of the MACD histogram. I'd expect anlarge short squeeze soon.
Long and hold $GSK ($MRNA $GILD $INO $SPY $PFE $JNJ $MRK)see full chart at www.tradingview.com
GSK
Entry $39.70
Target 1 $42.45
Target 2 $45.50
Target 3 $48
stoploss 38.70
Why this play?
There are 4 general approaches to the Covid vaccine.
1.A "killed" coronavirus that will get recognized as foreign matter in the blood. (Sinovac/Dynavax)
2.Coronavirus proteins themselves, produced industrially in outside cell cultures,
which will be recognized as foreign matter in the blood. (GlaxoSmithKline/Sanofi, Novavax)
3.A different virus (human or ape adenovirus, measles, etc) that is engineered
to include genetic components coding for the SARS-CoV-2 spike proteins,
which causes the body to then produce them. (CanSino, Oxford, J&J,
Merck/Themis)
4.DNA or RNA that will be taken up by cells and will cause them to make
coronavirus proteins. (Moderna, Innovio,
BioNTech/Pfizer)
GSK is #2, there is only 1 other big company doing this approach and that is NVAX.
We are betting on the fact that if they are successful, they could have super run like NVAX.
What is GSk?
www.gsk.com
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
We are heading down to the 200 EMA (low $16s) on the 4hr chartI expect a trend reversal once we hit the 200 EMA (golden line on bottom) with a slow climb back up. I am labeling this as a Long because it is bearish only for short term. The Stoch RSI has more room to move towards the oversold side but it should not be for more than a day, two max. I expect us to reverse trend from there and move on up with resistance close to $18, $18.90, and finally mid $19s. A close above mid $19s will be really good for long term. I have buys set at $16.30, $16, and $15.80 range. This is not financial advice. Just my opinion based on my analysis of the charts.
INO is sitting right at support. Great entry w/ 50% upsideINO is sitting right at support. Excellent entry point with at least 50% upside min in the short term.
My target is 24.36 --- let's do this!!!
INO: Potential head and shoulders spottedINO forming what seems to be a head and shoulders. Here is why I'm neutral on this:
Even though, Head and Shoulders is spotted, it has not break below the neckline for downward momentum. If it bounces off the neckline and breaks out of the descending trendline, then a downtrend would be invalidated and bulls would take over for that scenario. Be on the look out for a break below the neckline or a break above the descending trendline.
LONG - Strong trend on the 4 hour with great support. Great buying opportunity, with a excellent chance to break out of bull flag. A conservative trader would wait for the breakout, but I like the setup now near fib line.
Give me your thoughts
Bullish if stays in ChannelBeen watching this chart for 2 weeks now and finally testing support upwards channel which should happen within couple weeks. If hold great entry position to move to its resistance Trendline.
Not Financial Adviser Bla Bla ...but like if you Agree Thanks!
INOVIO (INO) to retest $8mostly retail interest in this company that has no approved vaccines to date.
LONG $AZN Covid wave 2 play ($MRNA $GILD $INO $SPY)see full chart at www.tradingview.com
AZN
Entry $54 area
Target $57
stoploss 53
Why this play?
Covid Vaccine stocks are hot right now, cases are rising = easy money.
What is AZN?
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology,
cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide.
The company serves primary care and specialty care physicians through distributors and local representative offices.
The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999.
INO dip anyone?Looks like INO is coming in for a dip buy opportunity!. A round and even number like $20 per share is still a good deal IMO>
